Redmon; Martin P.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Redmon; Martin P..The latest application filed is for "crystalline dipeptides useful in the synthesis of elamipretide".

Company Profile

3.10.14

Redmon; Martin P. - Boston MA
Redmon; Martin P. - Oxford MA
Redmon; Martin P. - Marlborough MA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Crystalline Dipeptides Useful In The Synthesis Of Elamipretide App 20210292274 - Duncan; Scott M. ; et al.	2021-09-23
Crystalline dipeptides useful in the synthesis of elamipretide Grant 10,975,118 - Duncan , et al. April 13, 2	2021-04-13
Crystalline Salt Forms App 20210047368 - Duncan; Scott M. ; et al.	2021-02-18
Crystalline Dipeptides Useful In The Synthesis Of Elamipretide App 20200283476 - Duncan; Scott M. ; et al.	2020-09-10
Crystalline salt forms Grant 10,683,326 - Duncan , et al.	2020-06-16
Crystalline Salt Forms App 20190382442 - Duncan; Scott M. ; et al.	2019-12-19
Purified pyrroloquinolinyl-pyrrolidine-2,5-dione compositions and methods for preparing and using same Grant 9,499,540 - Reed , et al. November 22, 2	2016-11-22
Topical Treatment Of Localized Scleroderma App 20160120865 - Trumbore; Mark W. ; et al.	2016-05-05
Purified Pyrroloquinolinyl-pyrrolidine-2,5-dione Compositions And Methods For Preparing And Using Same App 20160024076 - Reed; David P. ; et al.	2016-01-28
Purified pyrroloquinolinyl-pyrrolidine-2,5-dione compositions and methods for preparing and using same Grant 8,871,933 - Reed , et al. October 28, 2	2014-10-28
Purified Pyrroloquinolinyl-Pyrrolidine-2,5-Dione Compositions and Methods for Preparing and Using Same App 20140031551 - Reed; David P. ; et al.	2014-01-30
Purified pyrroloquinolinyl-pyrrolidine-2,5-dione compositions and methods for preparing and using same Grant 8,552,192 - Reed , et al. October 8, 2	2013-10-08
Purified Pyrroloquinolinyl-Pyrrolidine-2,5-Dione Compositions And Methods For Preparing And Using Same App 20110160242 - Reed; David P. ; et al.	2011-06-30
Hydroxy sulfonate of quinone compounds and their uses Grant 7,790,765 - Bartis , et al. September 7, 2	2010-09-07
Hydroxy sulfonate of quinone compounds and their uses App 20090028952 - Bartis; Judit ; et al.	2009-01-29
Lactose-free, non-hygroscopic and anhydrous pharmaceutical compositions of descarboethoxyloratadine App 20060079489 - Redmon; Martin P. ; et al.	2006-04-13
Norastemizole polymorphs Grant 6,627,646 - Bakale , et al. September 30, 2	2003-09-30
Norastemizole polymorphs App 20030100581 - Bakale, Roger P. ; et al.	2003-05-29
Stable Dosage Forms Of Fluoxetine And Its Enantiomers App 20030013740 - REDMON, MARTIN P. ; et al.	2003-01-16
Pharmaceutical compositions comprising norastemizole App 20020173522 - Redmon, Martin P. ; et al.	2002-11-21
Lactose-free, non-hygroscopic and anhydrous pharmaceutical compositions of descarboethoxyloratadine App 20020123504 - Redmon, Martin P. ; et al.	2002-09-05
Dosage form for aerosol administration Grant 6,161,536 - Redmon , et al. December 19, 2	2000-12-19
Formoterol process Grant 6,040,344 - Gao , et al. March 21, 2	2000-03-21

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.